Guofeng.L

I came, I saw, I conquered...

[The Scheibye-Knudsen Lab @ScheibyeKnudsen]

How do we allow everyone ownership in the next breakthrough drug for aging? And how do we fund the development? VitaDAO is the answer to both! Join the Gnosis auction now before it is too late (https://t.co/rC1LOcuAIh). Deadline on the 23rd!

https://t.co/fuNJYYP5fc

[NO-Age and NO-AD Joint Venture @NoAge100]

The 1st Hong Kong-Nordic Research Network meeting
16-17 June 2021, via zoom, free registration

(officiated by UiO Rector @sveinstlen in 2019)

Topics: #Ageing, #Alzheimer, #Cancer, #AI,

Registration: https://t.co/Dfp2VKr6qN
Programme: https://t.co/LAuw3Uy62P

[NO-Age and NO-AD Joint Venture @NoAge100]

The NO-Age and NO-AD Seminar Series 018
‘Mitochondrial genome mosaicism and resistance to damage’
by Dr. Steven Zuryn @ZurynLab
The University of Queensland, Australia
at 14:00-15:00 (CET), Monday, 07th June 2021
Register in advance for this webinar:
https://t.co/Cm8x74wjBw

[NO-Age and NO-AD Joint Venture @NoAge100]

Monday, 10th May 2021
14:00-15:15 (CET): ‘Searching for Anti-Aging Drugs and Anti-Aging Mechanisms’, Richard A. Miller
15:30-16:45 (CET): ‘Late life interventions to extend health and lifespan in mice’, Sarah J. Mitchell
Register:
https://t.co/oWW9yWlU6v

[NO-Age and NO-AD Joint Venture @NoAge100]

New hypothesis on Alzheimer's disease proposed by NO-AD members and colleagues: 'Re-emphasizing early Alzheimer’s disease pathology starting in select entorhinal neurons, with a special focus on mitophagy'. Link https://t.co/roEppqDOMP

[NO-Age and NO-AD Joint Venture @NoAge100]

Join us on this coming Monday (08 Feb 2021), 2 pm CET for a zoom meeting on how age and cardiovascular damages cause Alzheimer's disease.
Registration free here: https://t.co/xxTt0rNzYi

[NO-Age and NO-AD Joint Venture @NoAge100]

List of all NO-Age and NO-AD talks 2021 is here

For the 1st Feb 2021 (Monday), we will be featuring the AD legend Prof. John Hardy who proposed the Abeta hypothesis and a junior fellow Simon from the Tau leader Prof. Bradley Hyman lab. All meetings: https://t.co/m8oVRoi5Gm) .

[NO-Age and NO-AD Joint Venture @NoAge100]

Dear all, due to the many registrations, we have updated zoom to webinar, and thus please use the new link as a the attendee to join the webinar:
https://t.co/csrC6WYNEG
Name: The 1st NO-AD meeting (webinar)
Time: 09:20-16:30 (CET, Oslo time)
Details: https://t.co/30Cb0JNsOs

[FangGroup @TheFangGroupUiO]

The 7th anti-aging meeting is live now and will last for 4 days. Live Streaming
Access to this important meeting will only be available through live streaming which will be accessed by clicking the link below:
https://t.co/tV24z81pHG @NoAge100 @ScheibyeKnudsen

[AgingResearch @TheAgingField]

Great @AgingSciTalks from @Guofeng5658 from the @TheFangGroupUiO on the interconnected roles of compromised #mitophagy and #APOE4 in #AlzheimersDisease! ApoE4 #Celegans had impaired mitophagy and #memory, but #NR treatment extended #lifespan and improved #StressResistance.

[Aging Science Talks @AgingSciTalks]

Join us on Thursday at 1pm EST! @TheFangGroupUiO #healthyaging #ageing #mitophagy #APOE4

[NO-Age and NO-AD Joint Venture @NoAge100]

We perform fasting and exercise to keep our body healthy and brain sharp! Why they work?

The BBC interviewed, one of the world´s most cited neuroscientists Mark Mattson from @HopkinsMedicine, former @NIH will tell you on the 22th June via zoom https://t.co/oH8lHa5mzF

[Guofeng.L @Guofeng_L]

ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing Viral Infections Deplete NAD and SARS-CoV-2-Infected Cells Activate NAD Defense Pathway That Utilizes Nicotinamide Riboside (NR). 👍😇

[FangGroup @TheFangGroupUiO]

NAD+ may inhibit COVID-19: https://t.co/QZ5cyPBapo @CharlesMBrenner it reminds me of the anti-inflammation and autophagy-induction activities (NAD+ may increase autophagic elimination of exogenous invaded virus etc) of NAD+ we and others reported before. Cautiously optimistic!

[Guofeng.L @Guofeng_L]

One World: Together At Home🙏🤟😇 https://t.co/HejFD2RiEn
#TogetherAtHome #COVID19 @GlblCtzn @WHO

[FangGroup @TheFangGroupUiO]

How to maintain a young brain and a good memory when you are celebrating your 100th birthday? This is NO-AD Norway doing. We use the most advanced techniques to work on Alzheimer’s disease. https://t.co/DYDzh2foK8

[Guofeng.L @Guofeng_L]

Our paper "Mitophagy and Neuroprotection" in the 2020 new Special Issue: Mitochondria - From Diagnosis to Treatment on Trends in Molecular Medicine. @TrendsMolecMed @TheFangGroupUiO

[Trends in Molecular Medicine @TrendsMolecMed]

The January special issue “Mitochondria: From Diagnosis to Treatment” explores fundamental mechanisms of mitochondria in diverse pathologies as well as therapeutic strategies.

[Guofeng.L @Guofeng_L]

The genetics of human ageing https://t.co/yV4W5I9SGU

[FangGroup @TheFangGroupUiO]

@NoAge100 Thank you all for attending the 3rd NO-Age symposium: 'NAD+in healthy ageing and neurodegenerative diseases – from mechanisms to clinical studies'. Photo by NO-Age editor (@Nichev0 ). with @TheFangGroupUiO ; @BergersenL; @jon_storm; @CharlesMBrenner; @Arthurlou5658

[Guofeng.L @Guofeng_L]

@CellPressNews @UniOslo @TheFangGroupUiO Mitophagy and Neuroprotection

[Cell Press @CellPressNews]

Therapeutically targeting #mitophagy might inhibit neuronal loss in AD and PD. @UniOslo @TheFangGroupUiO #SfN19 https://t.co/nzLnKaI4x3